We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Biotechnology funding organization Cape Biotech has committed R6.7 million to
DISA Vascular, a Cape-based medical device company that develops innovative
vascular devices for the treatment of heart and peripheral vascular disease.
Chembio Diagnostics announced that it submitted an application to the FDA for
premarket approval (PMA) of its Sure Check HIV and HIV Stat-Pak rapid HIV tests.
Rochester Medical announced market introduction of
its Closed System Intermittent Catheter in both Hydrophilic Intermittent and
Antibacterial Hydrophilic Intermittent configurations.
Closure Medical has received the European Union's CE Mark approval for its proprietary
OMNEX Surgical Sealant, the company's first product indicated for use inside
the body.
Saft, a global multitechnology battery specialist, has announced that Cardiac
Science, a manufacturer of life-saving automatic external defibrillators (AEDs),
awarded Saft a three-year contract to be the turnkey provider of a complete
lithium battery power pack for Cardiac Science's G3 line of Powerheart AEDs.
Boston Scientific has completed enrollment in its ATLAS clinical trial, a global,
multicenter, pivotal study designed to support FDA approval of the Taxus Liberte
stent system.
BioniCare Medical Technologies announced a partnership agreement with RS Medical
to expand sales coverage of its physician-prescribed pulsed electrical stimulation
device for osteoarthritis of the knee -- the BIO-1000 System -- to more
than 150 metropolitan markets across the U.S. through the 300 sales people of
RS Medical.